The work of the Federal Trade Commission in cooperation with the Committee on Synthetic Drugs of the National Research Council in providing for the manufacture in this country of the important synthetic drugs which before the war were imported from abroad, and especially from Germany, has now passed through its first stage of development. Although supplies in some articles will not be overplentiful for some weeks yet, and plans for the manufacture of some important drugs, such as phenylbarbital (luminal) are still in the stage of preparative study only, the situation has defined itself so far that its further successful development can best be attained by the frank and hearty cooperation of the medical profession with the Federal Trade Commission and the National Research Council. The purpose of this series of short articles is to insure such cooperation, first by giving specific information to physicians, second, by requesting in return
STIEGLITZ J. SYNTHETIC DRUGS. JAMA. 1918;70(8):536–537. doi:https://doi.org/10.1001/jama.1918.26010080006009
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: